Analyst Price Target is $0.00
This price target is based on 1 analysts offering 12 month price targets for Kindred Biosciences in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.
Current Consensus is
The current consensus among 1 polled investment analysts is to hold stock in Kindred Biosciences. This Hold consensus rating has held steady for over two years.